Related Insights
Article
China’s rare disease drug development landscape: Overview and insights for global biopharmaceutical companies
Oct 22, 2026
Blog
Japan: the new strategic launchpad for accelerating global rare disease development
Jul 23, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
CTB Blog
Shaping a competitive, patient-centered future for Europe: Insights from the EURORDIS Round Table of Companies
Mar 5, 2026
Audiogram
New FDA regulatory initiatives improving rare disease drug development
Sep 23, 2025
Blog
Advancing rare disease research: Exploring opportunities for Bayesian methods with FDA’s upcoming guidance
Jun 17, 2025
Whitepaper
How real-world data is powering rare disease research Part 2. RWD advances in Europe
Apr 18, 2025
Whitepaper
How real-world data is powering rare disease research Part 3. RWD advances in China
Apr 18, 2025
Whitepaper
How real-world data is powering rare disease research Part 1. RWD advances in North America
Apr 18, 2025
Blog
Understanding mental health challenges in rare disease
Mar 4, 2025
Whitepaper
Early and often: reimagining patient community engagement to improve clinical trials feasibility
Feb 27, 2025
Related Insights
Article
China’s rare disease drug development landscape: Overview and insights for global biopharmaceutical companies
Oct 22, 2026
Blog
Japan: the new strategic launchpad for accelerating global rare disease development
Jul 23, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
CTB Blog
Shaping a competitive, patient-centered future for Europe: Insights from the EURORDIS Round Table of Companies
Mar 5, 2026
Audiogram
New FDA regulatory initiatives improving rare disease drug development
Sep 23, 2025
Blog
Advancing rare disease research: Exploring opportunities for Bayesian methods with FDA’s upcoming guidance
Jun 17, 2025
Whitepaper
How real-world data is powering rare disease research Part 2. RWD advances in Europe
Apr 18, 2025
Whitepaper
How real-world data is powering rare disease research Part 3. RWD advances in China
Apr 18, 2025
Whitepaper
How real-world data is powering rare disease research Part 1. RWD advances in North America
Apr 18, 2025
Blog
Understanding mental health challenges in rare disease
Mar 4, 2025
Whitepaper
Early and often: reimagining patient community engagement to improve clinical trials feasibility
Feb 27, 2025